Nu Skin Enterprises Inc. (NYSE: NUS) has reported its Q1 2025 revenue at the high end of its previously announced guidance, totaling $364.5 million, down 12.7% year-over-year. Despite ongoing macroeconomic headwinds, the company exceeded adjusted earnings expectations and signaled momentum in key global markets and innovation sectors.
Q1 Revenue: $364.5 million vs. $417.3 million (YoY decline of 12.7%)
FX impact: Negative 3.0% ($12.3 million)
Earnings per Share (EPS): $2.14 reported; $0.23 excluding Mavely gain and other charges
Customers: 776,712 (down 11%)
CEO Ryan Napierski stated:
“We are pleased to achieve revenue at the high end of our guidance and exceed our adjusted earnings forecast to start the year.”
Growth regions: Latin America and Rhyz manufacturing showed YoY improvement.
Challenges: Consumer hesitation due to inflation, tariffs, and premium beauty price sensitivity.
Innovation Focus: Nu Skin plans to launch the Prysm iO intelligent wellness device in late 2025, aiming to boost customer personalization and retention.
Expansion Strategy: India market pre-opening is expected in Q4, with formal entry slated for mid-2026.
| Metric | Q1 2025 | Q1 2024 | Change |
|---|---|---|---|
| Revenue | $364.5M | $417.3M | ↓ 12.7% |
| Gross Margin | 67.8% | 70.5% | ↓ |
| Selling Expenses | 32.5% | 36.8% | ↓ |
| G&A Expenses | 31.1% | 29.9% | ↑ |
| Operating Margin | (2.7)% | 2.1% | ↓ |
| Mavely Gain | $176.2M | — | — |
| Stock Repurchases | $5.0M | — | — |
Q2 Revenue: $355M–$390M
2025 Revenue Guidance: $1.48B–$1.62B
EPS Forecast: $2.80–$3.20 or $0.90–$1.30 (adjusted)
“We made progress improving our core operating margin and paid down $155 million in debt—our lowest level in over a decade. We remain committed to driving efficiency as we expand.”
The Nu Skin Enterprises Inc. operates through Nu Skin and Rhyz Inc. With a presence in 50+ markets, it leads in personal care, nutritional supplements, and ageLOC® beauty devices, powered by four decades of scientific research.
See more details
There are no reviews yet. Be the first one to write one.
